ARE YOU READY TO MOBILISE YOUR BUSINESS
With overwhelming evidence that mobile solutions are a huge part of our lives, it is surprising that there are so few options in support of both medical information and pharmacovigilance (PV) activities.
With overwhelming evidence that mobile solutions are a huge part of our lives, it is surprising that there are so few options in support of both medical information and pharmacovigilance (PV) activities.
Compliance with the new General Data Protection Regulation (GDPR), scheduled to become effective 25th May 2018, applies to all organizations that control or process personal data of European Union (EU) residents with or without a physical presence in the EU.
An integrated safety and pharmacovigilance software system with worldwide business ...
Compliance with the new General Data Protection Regulation (GDPR), scheduled to become effective 25th May 2018, applies to all organizations that control or process personal data of European Union (EU) residents with or without a physical presence in the EU.
Preparing to meet regulatory and commercial demands of the future requires a progressive, future-proof approach. As the regulatory department prepares for 2020
Cognitive computing has the potential to revamp the practice of pharmacovigilance, from a tedious, resource-intensive process to a dynamic and efficient practice.
The constant and critical push to accelerate a product’s time to market continues to push clinical teams to seek solutions that deliver greater efficiencies. But after 20 years of...
LifeSphere® Intake and Triage is the industry-leading multi-tenant cloud solution ...
The role of the Medical Information department and the part ...
At the center of these are your employees, and how their ability to work efficiently and effectively is affected by business, risk and IT concerns.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved